Table 4

Athletes with a new cardiac diagnosis: clinical characteristics

No.SexAge (years)SymptomsAbnormal finding at screening examinationExaminationsDiagnosisTherapyEligibility for sport
1M18NECGE, Ex, H, Ad, EPWPWAbY
2M28NECGE, Ex, H, AdWPWNY
3M32NECGE, Ex, H, AdWPWNY
4F18NECGE, Ex, H, ECG, GLQTS 1BBN
5M20NFH (BAV family)EBAVNY
6M25NPE (murmur)EBAV, AR 2+NY
7M21NPE (murmur)EBAV, AR 2+NY
8M34NPE (murmur)E, ExMVP, MR 2+NY
9M33NPE (murmur)E, ExMVP, MR 2+NY
10M27NPE (HTA)BPM, EHTANY
11M14YH (palpitations)E, Ex, HATNY
  • Ab, radiofrequency ablation of the accessory pathway; Ad, ECG with exposure to adenosine; AR 2+, mild aortic regurgitation; AT, atrial tachycardia; BAV, bicuspid aortic valve; BB, β-blockers; BPM, 24 h blood pressure monitoring; E, echocardiogram; Ex, exercise stress test; F, female; FH, family history; G, genetic testing; H, history; HTA, systemic hypertension; H, 24 h Holter monitoring; LQTS 1, long QT syndrome type 1; M, male; MVP, mitral valve prolapse; MR 2+, mild mitral regurgitation; N, no; PE, physical examination; WPW, Wolff-Parkinson-White; Y, yes.